Skip to content
Prescott Bio Canada

Epitalon: Research Summary

Published: 2026-08-03 · Last updated: 2026-08-03

Mechanism

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp- Gly) designed as a short mimic of the larger pineal peptide preparation Epithalamin, originally studied by the Khavinson group at the St. Petersburg Institute of Bioregulation and Gerontology. The most-cited proposed mechanism is upregulation of telomerase activity, with reported extension of telomere length in cultured somatic cells, along with modulation of pineal melatonin secretion and downstream circadian and neuroendocrine effects. The underlying molecular biology (how a tetrapeptide reaches the telomerase complex) remains an active question outside the original research group.

Published trials

The published literature is dominated by Russian-language and translated Russian-source papers from the Khavinson group and collaborators. Reported endpoints include telomerase induction and telomere elongation in cell culture, life-span extension in rodents, reduced spontaneous tumor incidence in aged mice, and endocrine-modulation and cardiovascular endpoints in small elderly-cohort clinical studies.

Independent replication outside the original research group is limited, and Western regulatory-standard RCT data at the scale of a registration trial does not exist. Cell-culture telomerase-induction findings have been partially replicated, but the pathway from a plasma-injected tetrapeptide to in vivo telomere elongation is not fully resolved in the peer-reviewed literature.

Safety profile

Rodent toxicology data reported in the Russian literature has not identified organ toxicity at typical research doses. Reported human exposure data comes from small elderly-cohort studies, which did not surface serious adverse events. Rigorous long-term controlled human safety data does not exist. Because telomerase upregulation is a theoretical oncology concern, the intersection of Epitalon and cancer risk is discussed in the literature but has not been characterized in human RCTs. Epitalon is not approved as a therapeutic drug by Health Canada, the FDA, or the EMA.

How it compares in its class

Epitalon is the most-cited member of a small class of "bioregulator peptides" studied within the Khavinson bioregulation framework, alongside Thymalin, Cortagen, Vilon, and others. Within longevity-oriented experimental peptides more broadly, its telomerase-modulation hypothesis makes it distinct from mitochondrial peptides like MOTS-c or NAD-precursor strategies. The evidence base is unusual in the peptide space in being heavily concentrated within a single research tradition; independent Western replication is the primary gap.

References

  • PMID: 12851079 — Khavinson VK et al., "Peptide regulation of gene expression and telomerase induction." Neuro Endocrinol Lett 2003.
  • PMID: 12817145 — Anisimov VN et al., Epitalon and life extension. Bull Exp Biol Med 2003.
  • PMID: 23057512 — Khavinson VK, "Peptide regulation of aging." Bull Exp Biol Med 2012.
  • DOI: 10.1007/s10517-014-2464-6 — Anisimov 2014 review of pineal peptide bioregulators.

Buy Epitalon in Canada: Prescott Bio Canada carries Epitalon vials — HPLC + mass-spec tested, ships from Richmond BC in 2-4 business days.